Your bridge into the GCC healthcare market
ZadValue helps pharmaceutical, biotech and MedTech companies in Canada, the US and Europe enter and grow in Saudi Arabia, the UAE, Qatar and the wider GCC, combining Western regulatory fluency with 30+ years of on-the-ground Gulf experience.
Four sectors, one point of accountability
Strategy, regulatory affairs, partnerships and operations, delivered by people who have launched products in these markets.
Pharmaceutical consulting
Strategy, market entry and regulatory guidance for pharmaceutical companies.
Learn moreBiotech consulting
Commercialization, licensing and access for biotechnology innovators.
Learn moreMedTech consulting
Regulatory strategy and market entry for devices and digital health.
Learn moreMedical nutrition consulting
Pathways and partnerships for clinical and therapeutic nutrition.
Learn moreDeep knowledge of the Gulf, connected to North America
Practical execution, not theory
We work alongside your team from the first market assessment to the first tender award.
- Deep regional expertiseHealthcare systems, regulatory frameworks and market dynamics across the Middle East.
- Regulatory affairs guidancePathways for pharmaceutical and MedTech products, designed to accelerate approvals.
- Strategic partnershipsIntroductions and structures that support long-term growth.
Figures as of January 2026.
From first assessment to sustained presence
Diagnose
Assess the product, the market and your readiness to enter.
Design
Choose the entry route, partners and regulatory pathway.
Execute
Submit, bid, launch and coordinate with local stakeholders.
Sustain
Build capability and operations that keep the market growing.
Plan your entry into the GCC
Tell us what you are launching and where, and we will propose the first step.